COVID-19 may also affect body composition, even in those who did not acquire the infection.
AstraZeneca fleshes out pivotal data on $930M rare blood disorder drug it wants to pair with Soliris, Ultomiris
AstraZeneca says its add-on pill for a rare blood disorder known as paroxysmal nocturnal hemoglobinuria, or PNH, helped patients already taking Ultomiris or Soliris produce
June 9, 2023